Adagene Inc. Sustainability Profile
Adagene Inc., a pioneering biotechnology company headquartered in China, focuses on the development of innovative antibody-based therapeutics. Founded in 2016, Adagene has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and precision medicine. The company is renowned for its proprietary technology platform, which enables the creation of next-generation antibodies with enhanced efficacy and safety profiles. Adagene's core products include its unique antibody drug conjugates and bispecific antibodies, setting it apart in a competitive market. With a strong presence in both domestic and international markets, Adagene has achieved significant milestones, including strategic partnerships and advancements in clinical trials, solidifying its position as a leader in antibody engineering and therapeutic development.
DitchCarbon Score
How does Adagene Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Adagene Inc.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Adagene Inc.'s reported carbon emissions
Adagene Inc., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Adagene may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, it is unclear how Adagene Inc. aligns with broader industry efforts to combat climate change. Without emissions data or reduction initiatives, the company's climate commitments remain unspecified, highlighting a potential area for future development in sustainability practices.
How Carbon Intensive is Adagene Inc.'s Industry?
How Carbon Intensive is Adagene Inc.'s Location?
Adagene Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Adagene Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
